Adel Mekhail - 15 Feb 2024 Form 4 Insider Report for Prestige Consumer Healthcare Inc. (PBH)

Role
EVP, Marketing & Sales
Signature
/s/ Adel Mekhail by William P'Pool as attorney-in-fact pursuant to power of attorney dated May 14, 2019 on file with the Commission
Issuer symbol
PBH
Transactions as of
15 Feb 2024
Net transactions value
-$492,156
Form type
4
Filing time
20 Feb 2024, 16:01:50 UTC
Previous filing
24 May 2023
Next filing
06 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PBH Common Stock, par value $0.01 per share Options Exercise $120,760 +4,000 +21% $30.19 22,681 15 Feb 2024 Direct
transaction PBH Common Stock, par value $0.01 per share Sale $276,840 -4,000 -18% $69.21 18,681 15 Feb 2024 Direct F1
transaction PBH Common Stock, par value $0.01 per share Options Exercise $461,729 +11,549 +62% $39.98 30,230 15 Feb 2024 Direct
transaction PBH Common Stock, par value $0.01 per share Sale $797,805 -11,549 -38% $69.08 18,681 15 Feb 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PBH Employee Stock Options (rights to buy) Options Exercise $0 -4,000 -100% $0.000000* 0 15 Feb 2024 Common Stock 4,000 $30.19 Direct F3
transaction PBH Employee Stock Options (rights to buy) Options Exercise $0 -11,549 -100% $0.000000* 0 15 Feb 2024 Common Stock 11,549 $39.98 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $68.79 to $69.21.
F2 Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $68.91 to $69.08.
F3 The options vested and became exercise on the third anniversary of the grant date.
F4 The options vested in three installments each of 3,850 shares on May 4, 2021 and May 4, 2022 and 3,849 shares on May 4, 2023.